We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sun Pharma Receives FDA OK to Make Generic Uroxatral
Sun Pharma Receives FDA OK to Make Generic Uroxatral
August 2, 2011
The FDA has approved Sun Pharmaceutical’s ANDA for a generic version of Sanofi’s prostate treatment Uroxatral XR, giving Sun 180 days of marketing exclusivity as the first filer.